ASX Announcement INOVIQ ANNOUNCES LEADERSHIP CHANGE Melbourne, Australia, 23 October 2026: INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a biotechnology company developing next-generation exosome-based diagnostics and therapeutics, today announced a planned leadership transition, with the Board...
INOVIQ Announces Leadership Change
Filed with ASX · · 1 page · English
Summary by 6ix AI
INOVIQ Ltd has announced a leadership change, with Dr. Leearne Hinch stepping down as CEO on a specified date. Peter Gunzburg will take over as Executive Chair on an interim basis while the company searches for a new CEO. The company plans to update the market on its future plans at the upcoming Annual General Meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Inoviq
- EXO-OC Technical Review and Commercialisation Pathway
- 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and Preliminary Financial Report
- Becoming a substantial holder
Later from Inoviq
- Notice of Annual General Meeting/Proxy Form
- INOVIQ receives $1.782m R&D Tax Incentive Refund
- Quarterly Activities Report and Appendix 4C - September 2026
- Board Changes
- IIQ signs EXO-OC validation agreement with Sonic Healthcare
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq